UW Medicine 2nd International Symposium on Merkel Cell Carcinoma 2022

Description

+ Include: 30 videos + 39 pdfs, size: 9.21 GB

+ Target Audience: oncologist

+ Sample video: contact me for sample video

+ Information:

The 2nd International Symposium on Merkel Cell Carcinoma (MCC) is designed to explore emerging data that may allow improvements in understand the basic biology that drives this disease, clinical guidelines, and to develop innovative approaches. Updates from the most recent clinical guidelines as well as emerging data regarding MCC biology are highlighted in plenary sessions. The educational purpose of this symposium is to disseminate emerging data and to advance MCC research through a stimulating and collaborative meeting.

The need for clinicians to continuously stay abreast of developments and current standards of care in the field of MCC is challenging because it is so rapidly evolving. Many clinicians are not familiar with how MCC differs from other skin cancers in its optimal management.

This activity will offer comprehensive reviews of the established standards of care and recent clinical advances in the field of MCC management, national cancer guidelines, and treatment recommendations in various clinical settings.

1. Address the outstanding questions in MCC basic biology and how they can lead to improvements in clinical care.
2. Identify the current clinical MCC biomarkers of disease burden and how to interpret those.
3. Review and discuss the updated national MCC clinical guidelines.

WHO SHOULD ATTEND
Healthcare providers including MDs, DOs, PhDs, other healthcare professionals, and scientists interested in MCC.

+ Topics:

‘Immunotherapy for solid organ transplant recipients with advanced MCC and other skin cancers.mp4
‘Immunotherapy for solid organ transplant recipients with advanced MCC and other skin cancers.pdf
Ablative Radiation Therapy for Merkel Cell Carcinoma.mp4
Ablative Radiation Therapy for Merkel Cell Carcinoma.pdf
Abstract- Development of a Merkel polyomavirus-specific T cell receptor analysis tool to guide cancer immunotherapy.mp4
Abstract- Development of a Merkel polyomavirus-specific T cell receptor analysis tool to guide cancer immunotherapy.pdf
Abstract- Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy.mp4
Abstract- Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy.pdf
Abstract- MCPyV ALTO is silenced in -virus-positive Merkel cell carcinoma and suppresses tumorigenesis.pdf
Abstract- Merkel polyoma virus specific transgenic T cell receptor therapy in PD-1 inhibitor refractory Merkel cell carcinoma.mp4
Abstract- Merkel polyoma virus specific transgenic T cell receptor therapy in PD-1 inhibitor refractory Merkel cell carcinoma.pdf
Abstract- Real-world assessment of ipilimumab plus nivolumab in anti-PD-L1 PD-1- refractory Merkel 1 Cell Carcinoma.mp4
Abstract- Real-world assessment of ipilimumab plus nivolumab in anti-PD-L1 PD-1- refractory Merkel 1 Cell Carcinoma.pdf
Abstract- The paranuclear dot in Merkel cell carcinoma, how does it form and what does it do..mp4
Abstract- The paranuclear dot in Merkel cell carcinoma, how does it form and what does it do..pdf
Animal Models of MCC.mp4
Animal Models of MCC.pdf
AST-008 and TLR9 agonists in Merkel cell carcinoma.mp4
AST-008 and TLR9 agonists in Merkel cell carcinoma.pdf
Avelumab in mMMC- real-world data.mp4
Avelumab in mMMC- real-world data.pdf
Can we harness T-cells specific for Merkel cell polyomavirus with therapuetic vaccination..mp4
Can we harness T-cells specific for Merkel cell polyomavirus with therapuetic vaccination..pdf
Clues to the Origins of Merkel Cell Carcinoma.mp4
Clues to the Origins of Merkel Cell Carcinoma.pdf
Contribution of Merkel Cell Polyomavirus to Merkel Cell Carcinoma.mp4
Contribution of Merkel Cell Polyomavirus to Merkel Cell Carcinoma.pdf
Cross-sectional Imaging In Merkel Cell Carcinoma- Is Less More..mp4
Cross-sectional Imaging In Merkel Cell Carcinoma- Is Less More..pdf
Diagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma.mp4
Diagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma.pdf
Epigenetic and Genetic Determinants of Merkel Cell Carcinoma.mp4
Epigenetic and Genetic Determinants of Merkel Cell Carcinoma.pdf
Featured Abstract- Virally mediated mechanisms of HLA class I loss in Merkel cell carcinoma and implications for viral epitope presentation.mp4
Featured Abstract- Virally mediated mechanisms of HLA class I loss in Merkel cell carcinoma and implications for viral epitope presentation.pdf
Immunotherapy Platform and Related-omics.mp4
Immunotherapy Platform and Related-omics.pdf
MCC Immunotherapy- Lessons Learnt and Unmet Needs.mp4
MCC Immunotherapy- Lessons Learnt and Unmet Needs.pdf
MCPyV-specific T cell discovery for adoptive T cell therapy.mp4
MCPyV-specific T cell discovery for adoptive T cell therapy.pdf
Mechanisms of Oncogenesis- MCC Cell of Origin.mp4
Mechanisms of Oncogenesis- MCC Cell of Origin.pdf
Merkel Cell Carcinoma in France- Characteristics of a Cohort of 1300 Patients.mp4
Merkel Cell Carcinoma in France- Characteristics of a Cohort of 1300 Patients.pdf
MJ2207 CME Questions Monday with ANSWERS.pdf
MJ2207 CME Questions Monday.pdf
MJ2207 CME Questions Tuesday with ANSWERS.pdf
MJ2207 CME Questions Tuesday.pdf
Neoadjuvant PD-1 Pathway Blockade for MCC- a window into treatment response and primary resistance.mp4
Neoadjuvant PD-1 Pathway Blockade for MCC- a window into treatment response and primary resistance.pdf
Q&A Summary.pdf
Randomized Phase II Study of NIVO + IPI vs. NIVO + IPI + SBRT in Metastatic or Recurrent Merkel Cell Carcinoma.mp4
Randomized Phase II Study of NIVO + IPI vs. NIVO + IPI + SBRT in Metastatic or Recurrent Merkel Cell Carcinoma.pdf
Real world management of MCC patients in France.mp4
Real world management of MCC patients in France.pdf
Registration & Breakfast.pdf
Role of radiotherapy in Merkel cell cancer.mp4
Role of radiotherapy in Merkel cell cancer.pdf
State of the Field- Merkel Cell Carcinoma.pdf
Surgery – Adjuvant RT.mp4
Surgery – Adjuvant RT.pdf
Systemic therapies for metastatic Merkel cell carcinoma.mp4
Systemic therapies for metastatic Merkel cell carcinoma.pdf
Transcriptional Responses to Type II Interferon Treatment in Merkel cell carcinoma.mp4
Transcriptional Responses to Type II Interferon Treatment in Merkel cell carcinoma.pdf
Update on Australian MCC Clinical Trials.mp4
Update on Australian MCC Clinical Trials.pdf
Welcome Remarks & Course Intro.pdf